New study aims to streamline uveitis diagnosis and cut costs
NCT ID NCT01162070
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at 905 people with uveitis, an eye inflammation, to see if a standardized step-by-step diagnostic plan works as well as letting doctors choose any tests they want. The goal was to find the cause of the uveitis more efficiently and at a lower cost. Researchers compared the percentage of patients diagnosed within six months using each strategy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more efficient and cost-effective way to diagnose the causes of uveitis, potentially improving patient care.
- What could go wrong
- This is an observational study comparing diagnostic strategies, not testing a new treatment. The results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
905 people
The number who actually took part.
- Start date
-
Jun 2010
- Finished
-
Jul 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Uveitis * Patient consulting one of the study's sites * Age \> 18 years old * Affiliation to the French national health insurance program * Patient agreeing to participate in the study Exclusion Criteria: * Positive HIV serology * Postsurgical or posttraumatic uveitis or endophthalmitis * Toxoplasmic uveitis * Pathology likely to be the cause of the known uveitis * Ophthalmic entities only diagnosed by the ophthalmic examination * Age \< 18 years old * Patient under law protection or guardianship * Pregnant women or those planning to be pregnant during the study * Severe uveitis (VA \< 20/200) with retinal vascularitis requiring an emergency treatment and assessment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Uveitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Interne, Hospices Civils de Lyon (HCL)-Hôpital de la Croix Rousse
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a biologic combo match steroids for uveitis?
- Can a High-Speed eye scan catch silent blinding disease in kids?
- A simple blood draw might reveal hidden eye lymphoma
- Can a new pill tame eye inflammation when others fail?
- Could a simple blood test allow uveitis patients to safely take less medication?
- New DNA test could revolutionize diagnosis of eye infections